Pendulum Therapeutics
PrivateLast Round
Seed
Feb 6, 2025
Est. Valuation
$175M
Total Funding Raised
$154M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pendulum Therapeutics is a biotechnology company that develops microbiome-targeted interventions and pharmaceuticals to manage chronic illnesses and improve metabolic health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Subscription Commerce, Clinical Trials
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pendulum Therapeutics Comparables
Compare Pendulum Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seed Health | 90% | |
| Viome Life Sciences, Inc. | 81% | |
| Supergut | 78% |
Pendulum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 6, 2025 | ||||
| Strategic | Jun 27, 2023 | ||||
| Angel | Feb 9, 2023 | ||||
| Series C | Apr 7, 2021 | ||||
| Series B | May 30, 2019 | ||||
Series A | May 30, 2018 |
Pendulum Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Series C, Series A, Series B |
| Sequoia Capital | Series C, Series A, Seed, Series B |
| Collaborative Fund | Seed |
| Morgan Noble Healthcare Partners | Series A |
| Mayo Clinic Ventures | Series C, Seed |
| Lowercarbon Capital | Seed |
| Cross Border Impact Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2026
iHerb identified as a key distribution channel.
- May 1, 2026
Reported explosive revenue and customer growth over the last two years.
Pendulum Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pendulum Therapeutics's valuation, stock price, and market status.
Is Pendulum Therapeutics a public or private company?
Pendulum Therapeutics is a private company.
What is the current stock price of Pendulum Therapeutics?
Pendulum Therapeutics is a private company, so its shares have no public market price. Caplight tracks Pendulum Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pendulum Therapeutics worth (valuation)?
Pendulum Therapeutics's valuation is estimated at $175.0M based on funding round data.
Can I buy Pendulum Therapeutics stock?
Pendulum Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pendulum Therapeutics's last funding round?
Pendulum Therapeutics's most recent funding round was Seed on February 6, 2025.
Who are the main investors in Pendulum Therapeutics?
Key investors in Pendulum Therapeutics include Sequoia Capital, Mayo Clinic Ventures, Meritech Capital Partners, True Ventures.
Will Pendulum Therapeutics IPO soon?
No public IPO plans have been announced for Pendulum Therapeutics.
How can I track Pendulum Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Pendulum Therapeutics's shares on secondary markets.